Glenmark Pharmaceuticals

Jul 31, 2015 at 11:50 | Source: Moneycontrol.com
It feels that US sales may see a pick-up in Q2. The company is also planning to file atleast 17-18 ANDAs in US this fiscal. However, volatility in emerging market currencies and consistent drop in sales in Venezuela remain a concern for the company.
Jul 31, 2015 at 11:11 | Source: CNBC-TV18
Given the numbers and the valuations the brokerage house would refrain from hiking the target price for Cipla from the current Rs 1070, Bhavesh Gandhi.
Jul 30, 2015 at 22:08 | Source: PTI
Glenmark Pharmaceuticals on Thursday posted 3.29 percent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets.
Jul 29, 2015 at 18:32 | Source: CNBC-TV18
Analysts expect US growth momentum (that picked up in Q4FY15) to continue in June quarter as well. US business is expected to be USD 92 million against USD 86.16 million in March quarter as approvals in the US picked up.
Jul 29, 2015 at 16:23 | Source: CNBC-TV18
Hemindra Hazari, independent market expert is of the view that Midcap pharma is going to be a better bet because large cap pharma.
Jul 29, 2015 at 11:13 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one should consider buying Glenmark Pharma.
Jul 29, 2015 at 07:56 | Source: PTI
The US District Court of Delaware at Wilmington, has said that claims of Bayer Healthcare Pharmaceuticals Inc, Intendis and Intraserv's litigation for Bayer's Finacea, a gel for treating the common skin condition rosacea against Glenmark is valid.
Jul 28, 2015 at 07:58 | Source: Reuters
The federal court in Wilmington, Delaware said Glenmark's proposed gel would be absorbed into the skin in a similar way to Finacea, violating Bayer's patent.
Jul 27, 2015 at 13:08 | Source: CNBC-TV18
Dipan Mehta - member at BSE & NSE maintains overweight position on pharma as well as private sector banks.
Jul 24, 2015 at 12:23 | Source: CNBC-TV18
Jeff Chowdhry, senior EM Fund Manager at LGM likes the pharma sector and prefer Lupin.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

371 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

414 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

8719 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.